Chronic allograft nephropathy: An update

被引:329
作者
Paul, LC [1 ]
机构
[1] Leiden Univ, Ctr Med, Dept Nephrol, NL-2300 RC Leiden, Netherlands
关键词
renal transplantation; transplant failure; immune-lymphatic theory; cytokines; graft injury;
D O I
10.1046/j.1523-1755.1999.00611.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Chronic allograft nephropathy is the most prevalent cause of renal transplant failure in the first post-transplant decade, but its pathogenesis has remained elusive. Clinically, it is characterized by a slow but variable loss of function, often in combination with proteinuria and hypertension. The histopathology is also not specific, but transplant glomerulopathy and multilayering of the peritubular capillaries are highly characteristic. Several risk factors have been identified, such as advanced donor age, delayed graft function, repeated acute rejection episodes, vascular rejection episodes, and rejections that occur late after transplantation. A common feature of chronic allograft nephropathy is that it develops in grafts that have undergone previous damage, although the mechanism(s) responsible for the progressive fibrosis and tissue remodeling has not yet been defined. Hypotheses to explain chronic allograft nephropathy include the immunolymphatic theory, the cytokine excess theory, the loss of supporting architecture theory, and the premature senescence theory. The most effective option to prevent chronic allograft nephropathy is to avoid graft injury from both immune and nonimmune mechanisms.
引用
收藏
页码:783 / 793
页数:11
相关论文
共 142 条
[1]   Unique changes in interstitial extracellular matrix composition are associated with rejection and cyclosporine toxicity in human renal allograft biopsies [J].
Abrass, CK ;
Berfield, AK ;
Stehman-Breen, C ;
Alpers, CE ;
Davis, CL .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 33 (01) :11-20
[2]   Macrophages and HLA-DR(+) cells in acutely rejecting kidney transplants, predict subsequent graft survival, even after reversal of the acute episode [J].
Alexopoulos, E ;
Leontsini, M ;
Papadimitriou, M .
NEPHROLOGY, 1998, 4 (1-2) :113-117
[3]   ROLE OF IRON AND OXYGEN RADICALS IN THE PROGRESSION OF CHRONIC-RENAL-FAILURE [J].
ALFREY, AC .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 23 (02) :183-187
[4]   RISK-FACTORS FOR CHRONIC REJECTION IN RENAL-ALLOGRAFT RECIPIENTS [J].
ALMOND, PS ;
MATAS, A ;
GILLINGHAM, K ;
DUNN, DL ;
PAYNE, WD ;
GORES, P ;
GRUESSNER, R ;
NAJARIAN, JS ;
FERGUSON ;
PAUL ;
SCHAFFER .
TRANSPLANTATION, 1993, 55 (04) :752-757
[5]   A randomized trial comparing cyclosporine and steroids with cyclosporine, azathioprine, and steroids in cadaveric renal transplantation [J].
Amenábar, JJ ;
Gómez-Ullate, P ;
García-López, FJ ;
Aurrecoechea, B ;
García-Erauzkin, G ;
Lampreabe, I .
TRANSPLANTATION, 1998, 65 (05) :653-661
[6]  
Amuchastegui SC, 1998, J AM SOC NEPHROL, V9, P1948
[7]   Patient survival after renal transplantation; more than 25 years follow-up [J].
Arend, SM ;
Mallat, MJK ;
Westendorp, RJW ;
vanderwoude, FJ ;
vanEs, LA .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (08) :1672-1679
[8]   Treatment of hyperlipidemia in renal transplant recipients [J].
Arnadottir, M ;
Berg, AL .
TRANSPLANTATION, 1997, 63 (03) :339-345
[9]   Genotypic variation in the transforming growth factor-β1 gene -: Association with transforming growth factor-pi production, fibrotic lung disease, and graft fibrosis after lung transplantation [J].
Awad, MR ;
El-Gamel, A ;
Hasleton, P ;
Turner, DM ;
Sinnott, PJ ;
Hutchinson, IV .
TRANSPLANTATION, 1998, 66 (08) :1014-1020
[10]  
AZIZ S, 1993, J HEART LUNG TRANSPL, V12, P634